ENGN included in ETFs
Dates are bounded by retained official portfolio snapshots; baseline presence is never presented as an original addition date.
Current ETFs holding ENGN
1 latest ETF portfolios currently report this security. This page shows rows 1–1 of 1.
| ETF | Fund | Weight | Added / first observed | Latest report |
|---|---|---|---|---|
| BBC | Virtus Biotech Clinical Trials Etf | 0.635294% | 2026-01-30 | 2026-04-30 |